Benchmarking the Extent and Speed of Reperfusion: First Pass TICI 2c-3 Is a Preferred Endovascular Reperfusion Endpoint
Background and Purpose: End-of-procedure substantial reperfusion [modified Treatment in Cerebral Ischemia (mTICI) 2b-3], the leading endpoint for thrombectomy studies, has several limitations including a ceiling effect, with recent achieved rates of ~90%. We aimed to identify a more optimal definiti...
Main Authors: | Albert J. Yoo, Jazba Soomro, Tommy Andersson, Jeffrey L. Saver, Marc Ribo, Hormozd Bozorgchami, Guilherme Dabus, David S. Liebeskind, Ashutosh Jadhav, Heinrich Mattle, Osama O. Zaidat |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.669934/full |
Similar Items
-
The effect of Nitroprusside on the renal ischaemia-reperfusion injury
by: Kadkhodaee M, et al.
Published: (2002-05-01) -
The effect of Nitroprusside on the renal ischaemia-reperfusion injury
by: Kadkhodaee M, et al.
Published: (2002-03-01) -
Which pathways trigger the role of complement in ischaemia/reperfusion injury?
by: Conrad Anthony Farrar, et al.
Published: (2012-11-01) -
Dexmedetomidine protects against myocardial ischaemia/reperfusion-induced renal damage in rats
by: Osama M. Assad, et al.
Published: (2018-01-01) -
Dexmedetomidine protects from post-myocardial ischaemia reperfusion lung damage in diabetic rats
by: Gülay Kip, et al.
Published: (2015-09-01)